TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express

Mar 13

TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.

At the session, directors will: 1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited. 2. Deliberate on the declaration of a final dividend, if any. 3. Consider closure dates for the register of shareholders, if required. 4. Determine the time, venue, and agenda of the forthcoming annual general meeting. 5. Address any additional matters placed before the Board.

The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1101353774"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101353774\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101353774?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101353774","market":"us","top_or_hot":-1,"title":"TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.</p>\n<p>At the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.</p>\n<p>The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.</p>\n<p>At the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.</p>\n<p>The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08189","symbol_name":"泰达生物","start_time":0,"source_url":"","article_id":"1101353774","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101353774","pubTimestamp":1773399631,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08189":"泰达生物"},"translate_title":"泰达生物医药(08189)定于2026年3月31日召开董事会批准2025财年业绩及股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08189":1},"content_text":"TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.\nAt the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.\nThe notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}